CDC73 and parathyroid gland carcinoma: Inactivating the CDC73 tumor suppressor gene (previously HRPT2) increases the susceptibility of heterozygous carriers to a range of conditions, including hyperparathyroidism-jaw (HPT-JT) syndrome, familial isolated hyperparathyroidism (FIHP), and parathyroid carcinoma (PC).